Dr. Mazyar Shadman joined Healthcare Unfiltered EXPRESS to share his insights on data-driven approaches to treating CLL in the front-line setting. Timely podcast as we approach the annual ASH 2025 meeting. Check it out, subscribe, and join the ...

Dr. Matt Lunning from the University of Nebraska simplifies how best we approach these aggressive diverse collections of lymphomas. Concise and straight to the point; check it out, subscribe, and join the conversation.

Dr. Matthew Kurian joins Healthcare Unfiltered EXPRESS to share his observations and insights on new emerging targets in breast cancer and how these targets are driving treatment selection across all disease stages. Please subscribe, review, an...

Dr. Karima Oualla joins the show to share how she brings research studies and scientific progress to clinical practice in Morocco. Despite limited resources, Dr. Oualla has pioneered research and cutting edge clinical care in her home country. ...

Should we treat cancers regardless of where they had originated from? Dr. Vivek Subbiah, world-renowned oncologist and researcher, joined Healthcare Unfiltered EXPRESS to advocate that this is the way of the future. A must listen episode lookin...

Dr. Anwaar Saeed joined Healthcare Unfiltered EXPRESS to discuss her recent paper published in The Lancet that addressed treating metastatic refractory colorectal cancers. Please share your thoughts and subscribe.

Dr. Karine Tawagi joins the show to detail prostate cancer data from ESMO 2025 that carries the most important clinical implications. What trial data mattered the most? Take a listen and join the conversation.

From Madrid, Dr. Enrique Grande joins Healthcare Unfiltered EXPRESS to share his thoughts and insights on data pertaining to renal cancer from the latest ESMO 2025 meeting. A 13-minutes that is worth your time. Please subscribe and join the con...

Dr. Bishoy Faltas, a world-renowned researcher with a focus on bladder and urothelial cancers, reflected on how the data from ESMO 2025 may shape current and future translational and bench research in these diseases. No one better than Bishoy t...

Dr. Petros Grivas from the Fred Hutch Cancer Center joins the show to share his timely insights on data presented at the ESMO 2025 meeting pertaining to urothelial cancers. Petros focuses on data that is practice changing or practice informing....

Dr. Sapna Patel, a world-renowned expert in melanoma from the University of Colorado, joins Healthcare Unfiltered EXPRESS to share new data and insights from the recently completed ESMO 2025 meeting in Berlin.Check it out, subscribe, share,...

Dr. Sarah Sammons of Dana-Farber Cancer Institute visits Healthcare Unfiltered EXPRESS to share timely and important insights and data from the ESMO 2025 congress that was recently concluded. Get up to speed with all data that has clinical impl...

Dr. Ari Rosenberg from the University of Chicago joins the show to share the most clinically relevant updates from the annual ESMO 2025 meeting that just concluded in Berlin. Check it out, and join the conversation.

Learn from Dr. Tim Brown what is new in adjuvant therapy for colon cancer.

The Annual AVBCC meeting takes place in NYC every year - if you did not attend, fear not as Dr. Doug Flora provides viewers and listeners of #HealthcareUnfiltered EXPRESS with behind the scene look at what happened at the meeting, its goals, ta...

In less than 10 minutes, Dr. Pal simplifies to everyone how best to manage papillary kidney cancer.

Learn about the AI powered Digital Twins and how they can help in unlocking the potential of expediting clinical trials and advancing clinical research.

Dr. Ray Rao, CEO of Ankr Health, shares his insights on how this government shutdown is affecting patients and families who are in urgent need for telehealth and telemedicine. Listen to this timely podcast and let's try to help all patients whe...

Dr. Nowakowski was at the ODAC meeting that denied Blenrep's indication, and he casted his vote. Learn from him what happened at the actual ODAC meeting, and what are the implication of the ODAC decision on this myeloma therapy.

Dr. Zeidan shares his thoughts on the recent news that the VERONA trial in high-risk MDS was negative.

Dr. Soror, a gradating fellow who just started her first year as an attending, shares with all what she wished she had known when she started her fellowship. Every Heme/Onc fellow must listen to this one.

Dr. Yelena Janjigian of Memorial Sloan Kettering Cancer Center joins the Healthcare Unfiltered Express to provide a timely and concise overview on how best to treat upper GI Cancers. So much data on IO in upper GI cancers and more to come at ES...

Lots of changes in managing advanced Hodgkin lymphoma especially with recent SWOG1826 data. Dr. Ann LaCasce provides an overview with excellent clinical pearls on how to approach this curabe malignancy.

Dr. Rana McKay visits the Healthcare Unfiltered EXPRESS to share her insights of how best to treat clear cell renal cell carcinoma - perfect listen ahead of the ESMO 2025 meeting happening this week as more GU oncology data emerges.Pleas...

Dr. Halmos from Montefiore in New York shares his views on the most impactful practice changing or informing data for lung cancer from the ASCO 2025 meeting.